These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9123720)

  • 1. Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone.
    Papadimitris C; Papadimitriou C; Kokolakis N; Athanassiades P; Dimopoulos MA
    Urology; 1997 Mar; 49(3):469-70. PubMed ID: 9123720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
    BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumors.
    Culine S; Philippot I; Farhat F; Théodore C; Terrier-Lacombe MJ; Droz JP
    Bull Cancer; 1997 Apr; 84(4):368-72. PubMed ID: 9238159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
    Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The chemotherapy of nonseminomatous testicular tumors].
    Tiuliandin SA; Bulanov AA; Titov DA; Sokolov AV; Sholokhov VN; Garin AM
    Urol Nefrol (Mosk); 1996; (2):26-9. PubMed ID: 8677548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
    Rick O; Siegert W; Beyer J
    Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
    Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
    Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two cases of relapse or refractory germ cell tumor who had been treated with combination chemotherapy of cisplatin and carboplatin].
    Kiyama Y; Suzuki G; Masauzi N; Ohizumi H; Kobayashi N; Ogasawara M; Naohara T; Saito M; Higa T; Kasai M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1989-92. PubMed ID: 8978809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of multimodality therapy of testicular germ cell tumor].
    Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of a non-seminomatous germ cell tumor in the seminal vesicle 20 years after initial diagnosis and treatment.
    Lattouf JB; Mc Cormack M; Yelle L; Hadjeres R; Saad F
    Can J Urol; 2004 Aug; 11(4):2350-1. PubMed ID: 15380057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
    Tanji S; Obara W; Sugimura J; Ohmori S; Matsushita Y; Tokunaga H; Konda R; Fujioka T; Murai K; Ishida Y
    Hinyokika Kiyo; 2004 Feb; 50(2):77-80. PubMed ID: 15101160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for testicular cancer.
    Xiao H; Sheinfeld J; Motzer RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 20. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.